Home › Forums › BIG PHARMA › Johnson & Johnson to acquire $2 billion drug developer “Ambrx Biopharma” to treat Turbo Cancers with same tech as Pfizer’s $43 billion Seagen acquisition. Both set their sights on 2025 Cancer TSUNAMI This topic is empty. Viewing 1 post (of 1 total) Author Posts 2024-01-17 at 18:25 #435696 Nat QuinnKeymaster https://makismd.substack.com/p/johnson-and-johnson-to-acquire-2 Author Posts Viewing 1 post (of 1 total) You must be logged in to reply to this topic. Log In Username: Password: Keep me signed in Log In
